本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aurinia Pharmaceuticals Inc

16.41
+0.31001.93%
盘后16.410.00000.00%19:30 EDT
成交量:75.35万
成交额:1,228.64万
市值:21.83亿
市盈率:7.12
高:16.52
开:16.03
低:15.93
收:16.10
52周最高:19.25
52周最低:10.34
股本:1.33亿
流通股本:1.29亿
量比:1.03
换手率:0.58%
股息:- -
股息率:- -
每股收益(TTM):2.30
每股收益(LYR):2.07
净资产收益率:66.12%
总资产收益率:15.49%
市净率:3.55
市盈率(LYR):7.93

数据加载中...

2019/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/25

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/08/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/04

超过5%披露

[Amend] General statement of acquisition of beneficial ownership